The results of a xenograft model of human melanoma using the MM466 and C918 cells were in line with in vitro findings and showed reduced growth of tumors in the combinatorial treatment groups compared to MEK inhibition alone or vehicle controls (Supplementary Figure 3B). The gene discussed is MAP2K7; the disease is melanoma.